WSA
SGMO

Wall Street Associates’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Wall Street Associates’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-81,440
Closed -$1.28M – 349
2015
Q1 		$1.28M Buy
+81,440
New +$1.26M 0.12% 188
2014
Q2 		– Sell
-134,428
Closed -$2.43M – 330
2014
Q1 		$2.43M Sell
134,428
-175,907
-57% -$3.39M 0.2% 154
2013
Q4 		$4.31M Sell
310,335
-18,740
-6% -$216K 0.35% 103
2013
Q3 		$3.45M Buy
+329,075
New +$3.27M 0.32% 110

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wall Street Associates's SGMO Position: Q2 2015 in Review

Wall Street Associates sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2015, closing a stake of 81,440 shares — an estimated $1.28M sold.

Wall Street Associates first reported a position in SGMO in Q3 2013 and held it in 4 quarters. The position peaked at $4.31M in Q4 2013. 156 funds tracked by Wall St. Rank hold SGMO as of Q2 2015.

  • Wall Street Associates reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2015 after selling out during the quarter.
  • Wall Street Associates sold 81,440 SANGAMO THERAPEUTICS INC shares in Q2 2015, an estimated $1.28M.
  • Wall Street Associates first reported a position in SANGAMO THERAPEUTICS INC in Q3 2013 and held it in 4 quarters.
  • Wall Street Associates's SANGAMO THERAPEUTICS INC position peaked at $4.31M in Q4 2013.
  • 156 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2015.

Based on Wall Street Associates's 13F filing for Q2 2015, filed 13 Aug 2015.